Retrovirox Inc

RetroVirox is a privately-held CRO exclusively focused on the virology field. RetroVirox offers a broad menu of antiviral and neutralization assays in a fee-for-service or F.T.E. pricing modality. Tests routinely performed in our laboratories include in vitro infectivity, replication, and neutralization assays to determine the antiviral activity of experimental drugs, and to evaluate candidate vaccines and antibodies. Assays against over a dozen different viruses have been validated and are offered to our customers. Customized assays are also available upon request. Since inception, RetroVirox has supported the preclinical discovery needs of hundreds of companies working on the virology field. Our customers include small start up, Biotechs, and large Pharmaceuticals in more than 20 countries in five continents. RetroVirox offers antiviral, neutralization, and vaccine testing services against multiple human viruses of commercial interest, including SARS-CoV-2, SARS-1, MERS, influenza (human and avian), RSV, HIV, adenovirus, rhinovirus, Lassa, Ebola, CMV, HSV-1/2, Dengue, Zika, human metapneumovirus, and other viral pathogens.More information about the antiviral services offered at RetroVirox is available at this link: https://retrovirox.com/Retrovirox_-_An_Integrated_Antiviral_Company.html RetroVirox is headquartered in San Diego, California: 7220 Trade St, Suite 338, San Diego, California 92121